FIELD: medicine.
SUBSTANCE: invention concerns treatments of the conditions caused by pathological metabolism of glucose and lipids. That is ensured by administration of cystamine or its salt in effective doses.
EFFECT: invention provides normalisation of such factors as C-peptide, uric acid, microalbumin, adiponectin.
17 cl, 11 tbl, 6 ex, 10 dwg
Authors
Dates
2010-04-27—Published
2005-04-29—Filed